Forum · Medicine · Story discussion
Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial
(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13…
2 days ago — MedPage Today · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…